ResMed Launches $450M Accelerated Share Repurchase with Citibank
RMD sits 28% above its 52-week low of $180.265.
Summary
ResMed entered a $450M accelerated share repurchase agreement with Citibank, funded by MatrixCare sale proceeds and cash, with initial delivery of 80% of shares on September 3, 2026 and final settlement in December 2026.
Key Events · Financing and Capital Events · RMD
-
$450M Accelerated Share Repurchase Executed
ResMed entered an ASR agreement with Citibank on August 31, 2026 to repurchase $450 million of common stock under its 2014 board authorization.
-
Initial Delivery of 80% of Shares
Citibank will deliver shares equal to 80% of $450M divided by the September 2, 2026 closing price on September 3, 2026, providing immediate share count reduction.
-
Funding from MatrixCare Sale Proceeds
The repurchase is funded by proceeds from the $490M MatrixCare divestiture and cash on hand, aligning with previously announced capital return plans.
-
Final Settlement in December 2026
Final share count will be based on volume-weighted average price during the ASR term, less a discount, with settlement scheduled for December 2026.
Analysis · RMD · Industrial Applications And Services
ResMed has executed a $450 million accelerated share repurchase agreement with Citibank, funded by proceeds from the MatrixCare divestiture and cash on hand. This is a significant capital return to shareholders, representing roughly 1.3% of the company's market capitalization. The ASR structure provides immediate share retirement (80% initial delivery) with final settlement in December 2026, reducing share count and supporting EPS. The transaction was previously signaled in Q4 FY26 earnings guidance, but the specific terms and counterparty are new disclosures.
How filings like this one have moved
In the 30 days to Sep 11, 2026, 30.5% of the 1973 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.21%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, RMD was trading at $231.36 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $33.4B. The 52-week trading range was $180.27 to $284.87. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.